Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.80 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.80 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.73 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.73 |
| ▸ | ATM | Q13315 | 1/20 | 0.73 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.37 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL2111757 | 1.00 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL10012517 | 1.00 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL2546264 | 1.00 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL6366220 | 0.95 | TSHR (0.73) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL27642068 | 0.95 | TSHR (0.73) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL2542609 | 0.95 | TSHR (0.73) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL2946116 | 0.95 | TSHR (0.73) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL29425321 | 0.95 | TSHR (0.73) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL9847141 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL7740438 | 0.95 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707909-A | Preparation method of fluoroethylene carbonate | 九江天赐高新材料有限公司 | 2025-03-28 | — | — | CN | claimed |
| US-20220185810-A1 | Novel Process for the Preparation of Filgotinib and Intermediates Thereof | UNICHEM LABORATORIES LIMITED (IN) | 2022-06-16 | — | — | US | claimed |
| EP-3947381-A2 | NOVEL PROCESS FOR THE PREPARATION OF FILGOTINIB AND INTERMEDIATES THEREOF | Unichem Laboratories Ltd (IN) | 2022-02-09 | — | — | EP | claimed |
| CN-113677676-A | Novel method for preparing non-gautinib and intermediate thereof | 联合化学实验室有限公司 | 2021-11-19 | — | — | CN | claimed |
| CN-112142821-A | Synthesis method and application of 9-fluoro steroid compound | 天津药业研究院股份有限公司 | 2020-12-29 | — | — | CN | claimed |
| CN-110373719-B | High-selectivity polysilicon etching solution and preparation method thereof | 湖北兴福电子材料有限公司 | 2020-12-15 | — | — | CN | claimed |
| WO-2020201975-A2 | NOVEL PROCESS FOR THE PREPARATION OF FILGOTINIB AND INTERMEDIATES THEREOF | UNICHEM LABORATORIES LIMITED (IN) | 2020-10-08 | — | — | WO | claimed |
| US-20250140548-A1 | PROCESSING SOLUTION, METHOD FOR PROCESSING SUBSTRATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE | TOKYO OHKA KOGYO CO., LTD, (JP) | 2025-05-01 | — | — | US | disclosed |
| US-20250140549-A1 | PROCESSING SOLUTION, METHOD FOR PROCESSING SUBSTRATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE | TOKYO OHKA KOGYO CO., LTD, (JP) | 2025-05-01 | — | — | US | disclosed |
| CN-119707909-A | Preparation method of fluoroethylene carbonate | 九江天赐高新材料有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-116836060-A | Preparation method of 2,3, 4-trifluoro nitrobenzene | 山东京博农化科技股份有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-111793182-B | Polyisocyanate composition | 万华化学集团股份有限公司 | 2022-04-22 | — | — | CN | disclosed |
| EP-2905361-B1 | METHOD OF FORMING A METAL COATING | TOYOTA MOTOR CO LTD (JP) | 2022-01-05 | — | — | EP | disclosed |
| US-8669382-B2 | Method for producing (2R)-2-fluoro-2-C-methyl-D-ribono-γ-lactone precursor | CENTRAL GLASS COMPANY, LIMITED (JP) | 2014-03-11 | — | — | US | disclosed |
| EP-2578578-A1 | METHOD FOR PRODUCING (2R)-2-FLUORO-2-C-METHYL-D-RIBONO- -LACTONE PRECURSOR | Central Glass Company, Limited (JP) | 2013-04-10 | — | — | EP | disclosed |
| US-20130072699-A1 | Method for Producing (2R)-2-Fluoro-2-C-Methyl-D-Ribono-y-Lactone Precursor | CENTRAL GLASS COMPANY, LIMITED (JP) | 2013-03-21 | — | — | US | disclosed |
| EP-2479203-A1 | AROMATIC POLYESTER | Muroran Institute of Technology (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120172570-A1 | AROMATIC POLYESTER | NITTA CORPORATION | 2012-07-05 | — | — | US | disclosed |
| US-6426865-B2 | Electric double layer capacitor | NEC CORPORATION (JP) | 2002-07-30 | — | — | US | disclosed |
| US-20010028546-A1 | Electric double layer capacitor | NEC CORPORATION (JP) | 2001-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220185810-A1 | Novel Process for the Preparation of Filgotinib and Intermediates Thereof | ABL1, JAK1, JAK3 | TSHR 868/4885NFKB1 2601/4885KCNA1 2452/4885 |
| US-20130072699-A1 | Method for Producing (2R)-2-Fluoro-2-C-Methyl-D-Ribono-y-Lactone Precursor | NSUN2, FBL, YTHDF2 | TSHR 2181/4885NFKB1 4778/4885KCNA1 2398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.